Concord Drugs soars on bagging orders worth Rs 14.71 crore in December
Concord Drugs is currently trading at Rs. 86.00, up by 2.89 points or 3.48% from its previous closing of Rs. 83.11 on the BSE.
The scrip opened at Rs. 80.32 and has touched a high and low of Rs. 86.40 and Rs. 80.32 respectively. So far 18232 shares were traded on the counter.
The BSE group 'X' stock of face value Rs. 10 has touched a 52 week high of Rs. 92.52 on 13-Nov-2025 and a 52 week low of Rs. 26.10 on 03-Mar-2025.
Last one week high and low of the scrip stood at Rs. 88.00 and Rs. 80.20 respectively. The current market cap of the company is Rs. 111.99 crore.
The promoters holding in the company stood at 54.39%, while non-institutions held 45.61% stake in the company.
Concord Drugs has secured purchase orders worth around Rs 14.71 crore from various entities, during the period of December, 2025. The orders are for supply of various pharmaceutical products and to be executed within 45 to 60 days.
Concord Drugs is engaged in developing new products Viz MUPS (Multiple Unit Pellet System), Sustained Release, Modified Release pellets with Innovative Drug Delivery Technologies by utilizing best and latest processing machinery.
